BioNexus Gene Lab Corp

General form for quarterly reports under Section 13 or 15(d)

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Other Events

Other Events

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d)

Notification of late filing of Form 10-K

Regulation FD Disclosure

Other Events

Other Events

Submission of Matters to a Vote of Security Holders

Other Events

Definitive Proxy Statement

Entry into a Material Definitive Agreement

General form for quarterly reports under Section 13 or 15(d)

Preliminary Proxy Statement

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Registration statement under Securities Act of 1933

Regulation FD Disclosure

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

Regulation FD Disclosure

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

General form for quarterly reports under Section 13 or 15(d)

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Annual report pursuant to Section 13 or 15(d) (amendment)

Annual report pursuant to Section 13 or 15(d)

Material Modifications to Rights of Security Holders

Material Modifications to Rights of Security Holders

Notification of late filing of Form 10-K

Submission of Matters to a Vote of Security Holders

Regulation FD Disclosure

Other Events

Required Information in Proxy Statement

Definitive Proxy Statement

Unregistered Sales of Equity Securities

Preliminary Proxy Statement

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

Definitive Proxy Statement

Preliminary Proxy Statement

General form for quarterly reports under Section 13 or 15(d)

Letter from the SEC

Annual report pursuant to Section 13 or 15(d) (amendment)

Annual report pursuant to Section 13 or 15(d) (amendment)

General form for quarterly reports under Section 13 or 15(d) (amendment)

General form for quarterly reports under Section 13 or 15(d) (amendment)

General form for quarterly reports under Section 13 or 15(d) (amendment)

Correspondence with the SEC

General form for quarterly reports under Section 13 or 15(d)

Letter from the SEC

Definitive information statement

No description available

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Prospectus Supplement with Pricing Information

Certification of approval for listing and registration on a national securities exchange

Notice of Effectiveness

Registration of Securities on Exchange

Amended Initial Registration Statement

Amended Initial Registration Statement

Definitive information statement

Amended Initial Registration Statement

No description available

Definitive information statement

Registration (IPO) statement under Securities Act of 1933

No description available

Notice of Effectiveness

Correspondence with the SEC

Correspondence with the SEC

Amended Initial Registration Statement

Letter from the SEC

Amended Initial Registration Statement

Letter from the SEC

Registration (IPO) statement under Securities Act of 1933

Chong Set Fui

Tan Lee Su-Leng

Low Jook Yuen

Bin Abdul Hamid Muhammad Azrul

Yap Chee Keong

FIDELION DIAGNOSTICS PTE. LTD.

Tan Lee Su-Leng

Chong Set Fui

Low Jook Yuen

Yap Chee Keong

Bin Abdul Hamid Muhammad Azrul

Liong Tai Tan

Leong Wei Li

Fong Yeat Min

Yap Chee Keong

Wong Yee Meng